Keytruda® (generic: pembrolizumab) is a humanized monoclonal antibody that works as an immune checkpoint inhibitor, targeting PD-1 (programmed death-1) to restore anti-tumor immune responses. First approved by the FDA in…
1. Introduction & Mechanism of Action Ipilimumab is a humanized IgG4 monoclonal antibody that selectively binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), an inhibitory receptor expressed on activated T cells…
BCC and SCC Skin is the largest organ of the human body. Among all cancers, skin cancer is considered the most common cancer developed in humans. Cancer means abnormal growth and…
